| Literature DB >> 35200389 |
Nana Yang1, Fengyu Liu2,3, Xinyue Zhang4,5, Chenni Chen2,3, Zhiyuan Xia6, Su Fu2,3, Jiaxin Wang2,3, Jingjing Xu1,7, Shuang Cui2,3, Yong Zhang2,3, Ming Yi2,3, You Wan2,3, Qing Li4,5, Shengyong Xu1.
Abstract
A transparent and penetrable cranial window is essential for neuroimaging, transcranial injection and comprehensive understanding of cortical functions. For these applications, cranial windows made from glass coverslip, polydimethylsiloxane (PDMS), polymethylmethacrylate, crystal and silicone hydrogel have offered remarkable convenience. However, there is a lack of high-strength, high-transparency, penetrable cranial window with clinical application potential. We engineer high-strength hybrid Titanium-PDMS (Ti-PDMS) cranial windows, which allow large transparent area for in vivo two-photon imaging, and provide a soft window for transcranial injection. Laser scanning and 3D printing techniques are used to match the hybrid cranial window to different skull morphology. A multi-cycle degassing pouring process ensures a good combination of PDMS and Ti frame. Ti-PDMS cranial windows have a high fracture strength matching human skull bone, excellent light transmittance up to 94.4%, and refractive index close to biological tissue. Ti-PDMS cranial windows show excellent bio-compatibility during 21-week implantation in mice. Dye injection shows that the PDMS window has a "self-sealing" to keep liquid from leaking out. Two-photon imaging for brain tissues could be achieved up to 450 µm in z-depth. As a novel brain-computer-interface, this Ti-PDMS device offers an alternative choice for in vivo drug delivery, optical experiments, ultrasonic treatment and electrophysiology recording.Entities:
Keywords: 3D printing; Ti-PDMS cranial window; high-strength; high-transparency; transcranial injection; two-photon imaging
Mesh:
Substances:
Year: 2022 PMID: 35200389 PMCID: PMC8870569 DOI: 10.3390/bios12020129
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Schematic representation of the fabrication processes of a Ti-PDMS transparent cranial window device. (A) The PDMS base elastomer and curing agent were mixed in a ratio of 10:1. (B) The PDMS solution was stirred and degassed in a mixer. (C) The PDMS solution contained in the sterile cell culture dish was degassed in a vacuum desiccator. (D) Fully dried Ti frame was slowly put into the PDMS solution and completely immersed. (E) The PDMS solution containing the Ti frame in the sterile cell culture dish was degassed again in a vacuum desiccator. (F) The PDMS solution containing the Ti frame in the sterile cell culture dish was placed on the optical platform to stand still. (G) The PDMS solution containing the Ti frame in the sterile cell culture dish was solidified in a convection oven incubator. (H) Ti-PDMS cranial window device was disconnected from the PDMS matrix along the outer edge with a scalpel.
Figure 2Optical images of the 3D printed Ti cranial frames with different shapes and sizes. (A–L) Small rectangular frames for mouse experiments. The orange dotted lines in (D,K) marked the locking parts on Ti frames, and the green dotted lines in (K) marked the clamping parts. (M,N) Rectangular frames for rat experiments. The orange and green dotted lines in (N), respectively, marked the locking and clamping parts on Ti frames. (O) A circular, curved frame for rat skull. (P) Photograph of a resin rat skull mold. (Q–W) 50 mm diameter circular Ti frames with hexagonal grid shape of different mesh sizes. (X) A close look at the Ti frame shown in (T), with grid length L of 3.5 mm, grid width w of 0.3 mm and the device thickness h of 1.0 mm.
Figure 3Images showing morphology and transparency of the Ti-PDMS cranial windows. (A,B) SEM images of the inner surface of as-fabricated Ti frame at different magnifications at (A) low and (B) high resolution. (C,D) SEM images of the sample after mechanical polishing process at different magnifications at (C) low and (D) high resolution. (E–H) Photographs of as-fabricated Ti-PDMS cranial windows, where a PDMS layer was mounted onto each polished Ti-frame. (I) Photograph of resin rat skull mold equipped with a curved Ti-PDMS cranial window. (J–L) Microscope images of the cranial windows in Figure (E–G), respectively, when they were placed on a silicon chip with a logo patterns.
Figure 4The proportion of transparent area (P) and mechanical property of a series Ti-PDMS cranial windows with diameter of 50.0 mm, grid width of 0.3 mm and device thickness of 1.0 mm. (A) P versus grid length of the Ti frames. Error bars indicated SD. (B) The electronic universal machine (left) and the schematic diagram for testing procedure (right). (C) A measured displacement-load curve taken from a sample with grid length of 2.0 mm and P 82%. The red dotted arrow indicates the fracture load. (D) The fracture load of Ti-PDMS cranial window samples versus the proportion of transparent area P. Error bars indicated SD.
Figure 5Optical properties of transparent Ti-PDMS cranial window. (A) A set of light transmittance-wavelength curves taken from 11 PDMS (thickness from 0.3 mm to 10.0 mm) and a #1 glass coverslip in the wavelength range of 250–1500 nm. Inset image showed the light transmittance of coverslip and PDMS with thickness of 0.3 mm and 0.5 mm in the wavelength range of 380–1500 nm. (B) An enlarged curves from (A) in the wavelength range of 380–1100 nm. (C) The average light transmittance in the wavelength range of 380–1100 nm for 2 PDMS sheets and #1 glass coverslip. Error bars indicated SD. (D) Refractive index data measured from 5 sites of a 4-inch diameter PDMS film in the wavelength range of 300–830 nm. (E) The high-resolution images of the fluorescent signal through PDMS. (F) The high-resolution images of the fluorescent signal through a glass coverslip.
Figure 6Implantation and functional evaluation of chronic Ti-PDMS cranial window. (A) Schematic diagram of a rodent with Ti-PDMS cranial window. (B) Schematic cross-section of a rodent with Ti-PDMS cranial window. (C) A typical photograph of one C57BL/6 mouse with Ti-PDMS cranial window. (D) Cortical images of the Ti-PDMS cranial window at D 0, D 1, W 2, W 4, W 13, W 16, W 19 and W 21 post-implantation.
Figure 7Dye injection of Hoechst 33258 and in vivo two-photon imaging through Ti-PDMS cranial window. (A–C) Schematic diagram of single site injection and imaging through Ti-PDMS cranial window. (D) Sequential images of the glass pipette placement and removal performed in 10 weeks post-implantation. A glass pipette was inserted into the brain tissue directly through the PDMS cover to avoid major vasculature. Hoechst 33258 (10 µg mL−1, 0.2 µL, 0.1 µL min−1) was injected into the brain. The blue arrow in the second and third images marked the liquid level. The black dashed lines inserted in the third image outlined the tip of the glass pipette. The yellow dashed line in the fourth image marked the injection site. The image inserted in the fourth image showed the enlarged view of the injection site, which was marked by the white arrow. (E) Two-photon imaging for Hoechst 33258 was possible up to 450 µm in z-depth.